Antidepressants

AHCPR Publication No. 93-0551 (1993, April). Depression Panel Guideline. Depression in primary care: Volume 2. Treatment of major depression. Clinical practice guideline, Number 5. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research.

American Psychiatric Association (APA). (1993). Practice guideline for major depressive disorder in adults. Am J Psychiatry, 150(4 Suppl.), 1–26.

APA. (1994). Diagnostic and statistical manual of mental disorders. 4th ed. Washington, D.C.: American Psychiatric Association.

Cohn C.K. Shrivastava R. Mendels J. Ereshefsky L. (1990). Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients. Journal of Clinical Psychiatry, 51(12 Suppl. B), 28–33.

Drug facts and comparisons. (1995, March). St. Louis: Wolters Kluwer Co.

Drug facts and comparisons. (1996, June). St. Louis: Wolters Kluwer Co.

Dunner D.L. Cohn J.B. Walshe T. III Rudorfer M.V. (1992). Two combined, multicenter, double-blind studies of paroxetine and doxepin in geriatric patients with major depression. Journal of Clinical Psychiatry, 53(2 Suppl.), 57–60.

Greenberg R.N. (1984). Overview of patient compliance with medication dosing: A literature review. Clinical Therapy, 6, 592–599.

Hutchinson D.R. Tong S. Moon C.A. Zussman B.D. (1991). A double-blind study in general practice to compare the efficacy and tolerability of paroxetine and amitriptyline in depressed elderly patients. British Journal of Clinical Research, 2, 43–57.

Kalayam B. , & Shamoian C.A. (1992). Treatment of depression: Diagnostic considerations. In: Salzman C. (Ed.). Clinical geriatric psychopharmacology. 2nd ed. Baltimore, MD: Williams & Wilkins.

Margolis S. , & Rabins P.V. (1996). Depression and anxiety. The Johns Hopkins white papers. Baltimore, MD: The Johns Hopkins Medical Institutions.

Montano C.B. (1994). Recognition and treatment of depression in a primary care setting. Journal of Clinical Psychiatry, 55(12 Suppl.), 18–34.

NIH Consensus Development Panel on Depression in Late Life (1993). Diagnosis and treatment of depression in late life. JAMA, 268, 1018–1024.

Physicians' desk reference. (1996). 50th edition. Montvale, NJ: Medical Economics Data Production.

Preskorn S.H. (1993). Recent pharmacological advances in antidepressant therapy for the elderly. American Journal of Medicine, 94(Suppl. 5A), 2S–12S.

Rudorfer M.V. , & Potter W.Z. (1989). Antidepressants: A comparative review of the clinical pharmacology and therapeutic use of the newer versus older drugs. Drugs, 37, 713–738.

Schone W. , & Lugdig M. (1993). A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression. Journal of Clinical Psychopharmacology, 13(Suppl. 2), 34S–39S.

Schweizer E. Weise C. Clary C. Keller M.B. (1991). Placebo-controlled trial of venlafaxine for the treatment of major depression. J Clin Psychopharmacol, 11, 233–236.

Seifert R.D. (1995). Management of depression in long-term care facility residents. Philadelphia: Medical Education Systems, Inc.

Sibert T. (1992). Depression: Treatment and management. Research Triangle Park, NC: Burroughs Wellcome Co.

Simonson W. (1995). Update on the treatment of depression. The Consultant Pharmacist, 10(Suppl. B), 3–4.

Tulloch I.F. , & Johnson A.M. (1992). The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor. Journal of Clinical Psychiatry, 53(Suppl.), 7–12.

Wells B.G. (1995). Issues in the diagnosis of major depression. Formulary, 30(Suppl. 1), S3–S9.